Department of Radiation Medicine & Applied Science - Open Access Policy Deposits

Parent: School of Medicine

eScholarship stats: Breakdown by Item for January through April, 2025

ItemTitleTotal requestsDownloadView-only%Dnld
7009d51pCancer-related Emergency Department Visits: Comparing Characteristics and Outcomes1311411710.7%
0v47k6m8NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018.100406040.0%
501663s9Review of the medical and legal literature on restraint chairs99247524.2%
7ph512rbAn Update on the Epidemiology, Molecular Characterization, Diagnosis, and Screening Strategies for Early-Onset Colorectal Cancer99198019.2%
0dn4070zCommon variants in breast cancer risk loci predispose to distinct tumor subtypes7896911.5%
2m29v9gsPsychological Impact and Coping Strategies of Hispanic Parents of Children with Cancer: A Qualitative Study78572173.1%
8mn2q2crAdditional SNPs improve risk stratification of a polygenic hazard score for prostate cancer787719.0%
9x51g6ffThe Role of Optical Surface Imaging Systems in Radiation Therapy77473061.0%
2vp3f7f7Sugar-sweetened beverages and colorectal cancer risk in the California Teachers Study723694.2%
4w7759k8Sugar‐Sweetened Beverage Intake and Cardiovascular Disease Risk in the California Teachers Study705657.1%
7zm3p2t3Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy705657.1%
2mg8p2dvHead and neck cancers, Version 2.2014. Clinical practice guidelines in oncology.69303943.5%
7vk9z4sqYoung-onset colorectal cancer risk among individuals with iron-deficiency anaemia and haematochezia691681.4%
8bd6h33bNCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.69294042.0%
8xt673k7Global challenges of radiotherapy for the treatment of locally advanced cervical cancer69492071.0%
3kx993d8Surgeon factors and their association with operating room turnover time68323647.1%
1bn7k4gcIdentification of ten variants associated with risk of estrogen-receptor-negative breast cancer6675910.6%
0xr1d56tPhysiological effects of a spit sock65125318.5%
4jb7x5fsDiffusion-Weighted Imaging in Cancer: Physical Foundations and Applications of Restriction Spectrum Imaging583555.2%
7806p41zPhase I Trial of Intravenous Oncolytic Vaccinia Virus (GL-ONC1) with Cisplatin and Radiotherapy in Patients with Locoregionally Advanced Head and Neck Carcinoma56124421.4%
3v22d5nxTranscriptome‐wide association study of breast cancer risk by estrogen‐receptor status544507.4%
7kj446gvDiscrimination Between Benign and Malignant Lesions With Restriction Spectrum Imaging MRI in an Enriched Breast Cancer Screening Cohort5164511.8%
39j6q6qvTargeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck50262452.0%
4q88c9d5Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2)50242648.0%
70t3d415Healthcare providers perspectives on home blood pressure management in Peru and Cameroon: Findings from the BPMONITOR study5074314.0%
7zp297pmAssociation analysis identifies 65 new breast cancer risk loci50183236.0%
55f8884vTrends in Radiation Therapy among Cancer Survivors in the United States, 2000–2030483456.3%
6650p24jTrends in emergency physician opioid prescribing practices during the United States opioid crisis47252253.2%
74s5j6qcReview article: Lynch Syndrome—a mechanistic and clinical management update473446.4%
0c84m60qRisk of Esophageal Cancer in Achalasia: A Matched Cohort Study Using the Nationwide Veterans Affairs Achalasia Cohort460460.0%
5550b9jzTechnical Note: Assessing the performance of monthly CBCT image quality QA46133328.3%
1qw7616rA randomized phase II trial of atezolizumab with or without tiragolumab before and after definitive chemoradiation for unresectable stage III non-small cell lung cancer (NSCLC; AFT-57)45123326.7%
8vg2f869A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data45103522.2%
4rd3g6zbScreening for Colorectal Cancer: The Role of Clinical Laboratories4483618.2%
6170b3nrPhysical activity, sedentary time and breast cancer risk: a Mendelian randomisation study4463813.6%
5n37184sThe Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)43123127.9%
0bb3x3s6Highly Efficient Training, Refinement, and Validation of a Knowledge-based Planning Quality-Control System for Radiation Therapy Clinical Trials42142833.3%
76b590qsThe COronavirus Pandemic Epidemiology (COPE) Consortium: A Call to Action4283419.0%
32d7c0zzCharacterization of Wnt Signaling Pathway Aberrations in Metastatic Prostate Cancer.413387.3%
6xm671c2Patterns of care in palliative radiotherapy: a population-based study.41162539.0%
76r6f8s5Effect of CD4 Count on Treatment Toxicity and Tumor Recurrence in Human Immunodeficiency Virus-Positive Patients With Anal Cancer.41132831.7%
7nt174hgModern Radiation Therapy and Cardiac Outcomes in Breast Cancer41221953.7%
16n4k476Feasibility of atlas-based active bone marrow sparing intensity modulated radiation therapy for cervical cancer40231757.5%
3480p381Robustness of a Restriction Spectrum Imaging (RSI) quantitative MRI biomarker for prostate cancer: assessing for systematic bias due to age, race, ethnicity, prostate volume, medication use, or imaging acquisition parameters40103025.0%
7930t4rsMAILED OUTREACH IS SUPERIOR TO USUAL CARE ALONE FOR COLORECTAL CANCER SCREENING IN THE UNITED STATES403377.5%
18w5121sPolygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.3953412.8%
1zw4b66xHead and Neck Cancers, Version 1.2015 Featured Updates to the NCCN Guidelines392375.1%
3v9686csDefinitive Radiation Therapy and Survival in Clinically Node-Positive Prostate Cancer.39132633.3%
08n8j47bA Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927)38122631.6%
0db624ssAssociation of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment3843410.5%

Note: Due to the evolving nature of web traffic, the data presented here should be considered approximate and subject to revision. Learn more.